Resources

Welcome to our searchable resource and literature collection on safer supply and related topics.

Found a broken link? Links do move around, so if you find one here that's broken, please let us know through the Contact form.

 

The effect of person, treatment and prescriber characteristics on retention in opioid agonist treatment: a 15-year retrospective cohort study

This study estimated retention in buprenorphine and methadone treatment and its relationship with person, treatment and prescriber characteristics.
Original research | 2021
About prescribers, Substitution/OAT

The GID-COVID Project: Gender and Intervention in Addiction with Individuals in Situations of Social Precarity in the Context of a Pandemic

WHO observed that the social fallout from COVID-19 hits women even harder (economic insecurity, single parenthood, violence, barriers to accessing services, etc.).
Lit review | 2020
Equity, Sex/Gender

The need to prioritize research, policy, and practice to address the overdose epidemic in smaller settings in Canada

Commentary | 2021
Mortality, Policy/Regulatory, Safer supply, Equity, Barriers and enablers, Housing, Rural/remote, Small/medium cities, Stigma

The opioid crisis in Canada: a national perspective

Evidence synthesis
Original research | 2018
Overdose, Mortality, Evidence base, Policy/Regulatory, Advocacy, Legal system/law enforcement, Illegal drugs, Indigenous, Sex/Gender

The regulation project: Tools for engaging the public in the legal regulation of drugs

This paper presents the work of an ongoing international collaboration of organizations advocating legal regulation and some of the knowledge translation tools used to educate and engage the public on
Commentary | 2020
Policy/Regulatory

What prescribers should know about COVID-19, Substance Use and Safe Supply: New provincial clinical guidance April 2020

Slide deck | 2020
Clinical guidance, Policy/Regulatory, Safer supply, About prescribers, Stimulants, Substitution/OAT, Transitions in care/treatment

“People need them or else they’re going to take fentanyl and die”: A qualitative study examining the ‘problem’ of prescription opioid diversion during an overdose epidemic

s.
Original research | 2021
Safer supply, Illegal drugs, Diversion

A cost-benefit and cost-effectiveness analysis of Vancouver's supervised injection facility

The purpose of this paper is to conduct a cost-effectiveness and cost-benefit analysis of this SIF using secondary data gathered and analysed in 2008.
Original research | 2010
Evidence base, Advocacy, Social benefits, SCS/OPS

Acceptability of, and barriers and facilitators to, a pilot physical health service for people who inject drugs: A qualitative study with service users and providers

This study explored the acceptability of, and barriers and facilitators to, embedding a pilot physical healthcare service within a community-based drug service in the United Kingdom (Bristol, England)
Original research | 2022
Wrap-around services, Social services, Barriers and enablers, Stigma

Addressing COVID-19 Among People Experiencing Homelessness: Description, Adaptation, and Early Findings of a Multiagency Response in Boston

Describes a city-wide COVID-19 care model for the homeless population
Case study | 2020
Harm reduction, Social services, Housing

Addressing the dual public health emergency: supporting physicians to prescribe opioid medications

Response to Tyndall 2020 (A safer drug supply…)
Letter | 2020
Hesitancy of prescribers , About prescribers

Associations of retention on buprenorphine for opioid use disorder with patient characteristics and models of care in the primary care setting

This study examines patient correlates of buprenorphine retention and whether an integrated, interdisciplinary treatment model (buprenorphine and behavioral health) is associated with higher odds of b
Original research | 2021
About prescribers, Outcomes, Substitution/OAT, Mental health

Availability and use of non-prescribed buprenorphine-naloxone in a Canadian setting, 2014–2020

In Canada, restrictions on BUP-NX prescribing were relaxed in 2016, which may have had an effect on rates of diversion and non-prescribed use.
Original research | 2022
Hesitancy of prescribers , About PWUD, Substitution/OAT, Diversion

Changes in substance supply and use characteristics among people who use drugs (PWUD) during the COVID-19 global pandemic: A national qualitative assessment in Canada

The current study examined how COVID-19 has impacted substance use supply and use characteristics among a national cohort of PWUD in Canada.
Original research | 2021
Overdose, Evidence base, Harm reduction, Policy/Regulatory, Safer supply, Advocacy, About PWUD

Development of a filter to prevent infections with spore-forming bacteria in injecting drug users

Our aim was to develop a filter that efficiently removes spore-forming bacteria and is also likely to be acceptable for use by people who inject drugs (i.e. quick, simple and not spoil the hit).
Original research | 2016
Harm reduction, Safer supply, About PWUD, Injecting drugs

Experiences with the Philadelphia police assisted diversion program: A qualitative study

Philadelphia launched a Police Assisted Diversion (PAD) program to address the highest rates of poverty, incarceration, and fatal overdose among large cities in the U.S.
Original research | 2022
Social services, Housing, Crime, Legal system/law enforcement, Illegal drugs

Harm Reduction at Work: A Guide for Organizations Employing People Who Use Drugs

The key goal of this guide is to help harm reduction organizations and drug policy advocates hire and work with active drug users

Guidelines | 2010
Policy/Regulatory, About PWUD, Workplace, Substitution/OAT, Peer/PWLLE program involvement, Harm reduction

Health care-seeking experiences for people who inject drugs with hepatitis C: Qualitative explorations of stigma

For PWID, intersectional experiences of stigma and other social vulnerabilities may influence their experiences navigating medical care.
Original research | 2021
About pharmacists, About PWUD, Barriers and enablers, Poverty, Illegal drugs, Stigma

Injectable Opioid Agonist Treatment

Webpage | 2020
Safer supply, Advocacy

Investigating the impacts of COVID-19 among LGBTQ2S youth experiencing homelessness

this study aimed to understand the impacts of the COVID-19 pandemic on LGBTQ2S youth at risk of, and experiencing, homelessness in the Greater Toronto Area, Ontario, Canada and surrounding areas.
Original research | 2021
About PWUD, Housing, Youth, 2SLGBTQI+

Refine Your Search

Keywords
Format
Region